This framework has expired
View all live frameworks
Homecare Medicines Services for Immunoglobulin Therapies (Ref: 2020/S 127-312140)
Background
The Homecare Medicines Services for Immunoglobulin Therapies framework agreement, operating on a hub and spoke model with specialist centre prescribing, addresses a market area with an annual spend of approximately £8 million for products and services in the East of England.
Open to member organisations of the East of England NHS Collaborative Procurement Hub, associate members, and other publicly funded bodies, participating organisations are primarily located in the East of England, South East Coast, and Thames Valley and Wessex regions. This framework sustains the aggregated procurement approach in the area of Immunoglobulin Therapies, building on years of experience and expertise.
Benefits
- Competitive prices fixed for a two-year period
- Complaint route for homecare medicines service
- Robust call-off procedure and innovative Key Performance Indicators to support improved contract and market engagement
- Utilisation of standard national specification and Key Performance Indicators
- Wide choice of awarded supplier and service level to suit local requirements
Start date
End date
Contract type
Framework Agreement
Framework owner
ABI
Award type
Further competition
List of suppliers and awarded lots
Alcura Uk Limited, Calea UK Limited, Healthcare at Home ltd, Lloyds Pharmacy Clinical Homecare, Pharmaxo Pharmacy Services Ltd, Polar Speed Distribution Limited.
Access the framework documents
If you have a login to our sharepoint, you can access the framework documents below.